Summary
Schering-Plough sues to defend drug patent
KENILWORTH Schering-Plough Corp. sued India's Glenmark Pharmaceuticals Ltd. to block regulatory approval of a generic version of Zetia, the world's fourth-most prescribed cholesterol drug.See the full content of this document
Extract
N.J. Briefs
Glenmark, based in Mumbai, has asked the U.S. Food and Drug Administration for permission to sell a low-cost version of the drug. Schering-Plough says the ...
See the full content of this document
Sponsored links
